Showing results (211-220 of 320) with videos related to

Sort By:
Pageof 32
Breast Cancer Research and Treatment|January 30, 2007
Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancerGerwin Heller, Joseph Geradts, Barbara Ziegler, et al.
International Journal of Molecular Sciences|January 8, 2025
Precision Oncology Approach for Urachal Carcinoma: A Clinical Case ReportDániel Juhász, Anita Csizmarik, János Szalontai, et al.
Communications Chemistry|January 25, 2023
Landomycins as glutathione-depleting agents and natural fluorescent probes for cellular Michael adduct-dependent quinone metabolismAlessio Terenzi, Mery La Franca, Sushilla van Schoonhoven, et al.
Journal of Medicinal Chemistry|October 5, 2010
{(1R,2R,4R)-4-methyl-1,2-cyclohexanediamine}oxalatoplatinum(II): a novel enantiomerically pure oxaliplatin derivative showing improved anticancer activity in vivoSergey A Abramkin, Ute Jungwirth, Seied M Valiahdi, et al.
Molecular Cancer|April 30, 2013
Hellebrin and its aglycone form hellebrigenin display similar in vitro growth inhibitory effects in cancer cells and binding profiles to the alpha subunits of the Na+/K+-ATPaseLaetitia Moreno Y Banuls, Adriana Katz, Walter Miklos, et al.
Scientific Reports|November 19, 2020
Multicellular contractility contributes to the emergence of mesothelioma nodulesJulia Tarnoki-Zach, Paul Stockhammer, Dona Greta Isai, et al.
Dalton Transactions (Cambridge, England : 2003)|September 2, 2017
Synthesis and in vivo anticancer evaluation of poly(organo)phosphazene-based metallodrug conjugatesCarmen M Hackl, Beatrix Schoenhacker-Alte, Matthias H M Klose, et al.
Frontiers in Medicine|June 6, 2022
Heme Biosynthesis Factors and 5-ALA Induced Fluorescence: Analysis of mRNA and Protein Expression in Fluorescing and Non-fluorescing GliomasMario Mischkulnig, Thomas Roetzer-Pejrimovsky, Daniela Lötsch-Gojo, et al.
Blood|January 12, 2017
Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolismJulia Riedl, Matthias Preusser, Pegah Mir Seyed Nazari, et al.
Experimental Hematology & Oncology|August 23, 2025
The anticancer thiosemicarbazone triapine exerts immune-enhancing activities via immunogenic cell death induction and FAS upregulationBianca Stiller, Alessia Stefanelli, Hemma Schueffl, et al.
Pageof 32